Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001244607 | SCV001417837 | pathogenic | Multiple endocrine neoplasia, type 2 | 2020-08-04 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Pro384Glnfs*29) in the RET gene. It is expected to result in an absent or disrupted protein product. For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in RET are known to be pathogenic (PMID: 22174939, 22648184). This variant has not been reported in the literature in individuals with RET-related conditions. This variant is not present in population databases (ExAC no frequency). |